Beta blockers in patients with end-stage renal disease-Evidence-based recommendations.


eMediNexus    05 March 2018

A new article published in Seminars in Dialysis reported that for patients who require hemodialysis, beta blockers offer opportunity as well as challenge in the treatment of cardiovascular disease. This article discussed that beta blockers directly alleviate sympathetic overactivity that links chronic kidney disease with cardiovascular sequelae. The authors stated that trial and observational data can help guide the use of these medications in patients receiving hemodialysis. This review article highlighted the reasons behind considering beta blockers for patients receiving hemodialysis, discussed the barriers to their use, and provided specific evidence-based recommendations for beta blocker use in patients with heart failure, hypertension, ischemic heart disease, and arrhythmia.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.